These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25567202)

  • 1. Metabolomic serum profiling detects early-stage high-grade serous ovarian cancer in a mouse model.
    Jones CM; Monge ME; Kim J; Matzuk MM; Fernández FM
    J Proteome Res; 2015 Feb; 14(2):917-27. PubMed ID: 25567202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Metabolomics of a High-Grade Serous Ovarian Cancer Triple-Knockout Mouse Model.
    Huang D; Gaul DA; Nan H; Kim J; Fernández FM
    J Proteome Res; 2019 Aug; 18(8):3184-3194. PubMed ID: 31290664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly-accurate metabolomic detection of early-stage ovarian cancer.
    Gaul DA; Mezencev R; Long TQ; Jones CM; Benigno BB; Gray A; Fernández FM; McDonald JF
    Sci Rep; 2015 Nov; 5():16351. PubMed ID: 26573008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary hydrophilic and hydrophobic metabolic profiling based on liquid chromatography-mass spectrometry methods: Differential metabolite discovery specific to ovarian cancer.
    Chen J; Zhou L; Zhang X; Lu X; Cao R; Xu C; Xu G
    Electrophoresis; 2012 Nov; 33(22):3361-9. PubMed ID: 23109122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Biomarkers and Metabolic Profiling of Serum in Ovarian Cancer Patients Using UPLC/Q-TOF MS.
    Yang W; Mu T; Jiang J; Sun Q; Hou X; Sun Y; Zhong L; Wang C; Sun C
    Cell Physiol Biochem; 2018; 51(3):1134-1148. PubMed ID: 30476914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer detection using targeted plasma metabolomics.
    Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer.
    Kozar N; Kruusmaa K; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Arko D; Takač I
    Clin Chim Acta; 2018 Jun; 481():108-114. PubMed ID: 29481776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole Reproductive System Non-Negative Matrix Factorization Mass Spectrometry Imaging of an Early-Stage Ovarian Cancer Mouse Model.
    Paine MR; Kim J; Bennett RV; Parry RM; Gaul DA; Wang MD; Matzuk MM; Fernández FM
    PLoS One; 2016; 11(5):e0154837. PubMed ID: 27159635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
    Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors.
    Buas MF; Gu H; Djukovic D; Zhu J; Drescher CW; Urban N; Raftery D; Li CI
    Gynecol Oncol; 2016 Jan; 140(1):138-44. PubMed ID: 26521694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
    J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Segregation of ovarian cancer stage exploiting spectral biomarkers derived from blood plasma or serum analysis: ATR-FTIR spectroscopy coupled with variable selection methods.
    Lima KM; Gajjar KB; Martin-Hirsch PL; Martin FL
    Biotechnol Prog; 2015; 31(3):832-9. PubMed ID: 25832726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Li Y; Song X; Zhao X; Zou L; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
    He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
    Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra‑performance liquid chromatography coupled with quadrupole time‑of‑flight mass spectrometry‑based metabolic profiling of human serum prior to and following radical resection of colorectal carcinoma.
    Chen L; Zhang C; Gui Q; Chen Y; Yang Y
    Mol Med Rep; 2015 Nov; 12(5):6879-86. PubMed ID: 26352758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded metabolomics approach to profiling endogenous carbohydrates in the serum of ovarian cancer patients.
    Cheng Y; Li L; Zhu B; Liu F; Wang Y; Gu X; Yan C
    J Sep Sci; 2016 Jan; 39(2):316-23. PubMed ID: 26549419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry.
    Zhang T; Wu X; Yin M; Fan L; Zhang H; Zhao F; Zhang W; Ke C; Zhang G; Hou Y; Zhou X; Lou G; Li K
    Clin Chim Acta; 2012 May; 413(9-10):861-8. PubMed ID: 22309680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of detecting prostate cancer by ultraperformance liquid chromatography-mass spectrometry serum metabolomics.
    Zang X; Jones CM; Long TQ; Monge ME; Zhou M; Walker LD; Mezencev R; Gray A; McDonald JF; Fernández FM
    J Proteome Res; 2014 Jul; 13(7):3444-54. PubMed ID: 24922590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
    Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
    Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.